We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+10.93%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$3.18B
AUM Growth
-$2.44B
Cap. Flow
-$2.64B
Cap. Flow %
-83.08%
Top 10 Hldgs %
60.78%
Holding
672
New
112
Increased
61
Reduced
251
Closed
169

Top Buys

Rank Stock Value
1
PXD
Pioneer Natural Resource Co.
PXD
+$604M
2
SPLK
Splunk Inc
SPLK
+$446M
3
HES
Hess
HES
+$339M
4
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
+$106M
5
X
US Steel
X
+$50.9M

Top Sells

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$1.06B
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$887M
3
SGEN
Seagen Inc. Common Stock
SGEN
+$371M
4
VMW
VMware, Inc
VMW
+$354M
5
NEWR
New Relic, Inc.
NEWR
+$284M

Sector Composition

Rank Sector Weight
1 Energy 29.51%
2 Technology 21.97%
3 Healthcare 10.49%
4 Real Estate 7.26%
5 Industrials 4.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RCUS icon
251
Arcus Biosciences
RCUS
$3.62B
$1.02M 0.03%
53,246
-46,166
-46% -$738K
EXR icon
252
Extra Space Storage
EXR
$31.8B
$1.01M 0.03%
6,325
-78,576
-93% -$9.99M
SYRS
253
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$1.01M 0.03%
+130,000
New +$445K
NOW icon
254
ServiceNow
NOW
$130B
$999K 0.03%
7,070
-30,430
-81% -$3.84M
PTCT icon
255
PTC Therapeutics
PTCT
$5.98B
$994K 0.03%
36,052
-6,549
-15% -$150K
AKTS
256
DELISTED
Akoustis Technologies Inc
AKTS
$984K 0.03%
1,180,000
+980,000
+490% +$659K
HLVX
257
DELISTED
HilleVax
HLVX
$980K 0.03%
61,059
-53,419
-47% -$710K
VRNA
258
DELISTED
Verona Pharma
VRNA
$965K 0.03%
48,533
-39,095
-45% -$577K
RVNC
259
DELISTED
Revance Therapeutics, Inc.
RVNC
$964K 0.03%
109,667
+20,867
+23% +$171K
AXSM icon
260
Axsome Therapeutics
AXSM
$10.8B
$949K 0.03%
11,922
-13,813
-54% -$923K
TEVA icon
261
Teva Pharmaceuticals
TEVA
$41.1B
$940K 0.03%
90,017
-94,983
-51% -$887K
AXGN icon
262
Axogen
AXGN
$2.41B
$940K 0.03%
137,575
-101,621
-42% -$565K
JD icon
263
JD.com
JD
$44.4B
$939K 0.03%
+32,500
New +$881K
WH icon
264
Wyndham Hotels & Resorts
WH
$5.52B
$919K 0.03%
11,428
-160,443
-93% -$12.1M
IOVA icon
265
CALL
Iovance Biotherapeutics
IOVA
$2.76B
$900K 0.03%
330,000
+100,000
+43% +$523K
IMUX icon
266
Immunic
IMUX
$211M
$900K 0.03%
60,023
-16,146
-21% -$198K
PTON icon
267
PUT
Peloton Interactive
PTON
$2.44B
$899K 0.03%
1,037,500
– –
SILK
268
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$890K 0.03%
72,556
+26,028
+56% +$244K
SAVE
269
PUT
DELISTED
Spirit Airlines, Inc.
SAVE
$885K 0.03%
300,000
-150,000
-33% -$2.16M
META icon
270
Meta Platforms (Facebook)
META
$1.52T
$885K 0.03%
2,500
-5,000
-67% -$1.63M
ETNB
271
DELISTED
89bio
ETNB
$883K 0.03%
79,075
-19,763
-20% -$182K
TRIS
272
DELISTED
Tristar Acquisition I Corp.
TRIS
$870K 0.03%
80,656
-36,254
-31% -$390K
SUI icon
273
Sun Communities
SUI
$14.7B
$853K 0.03%
6,379
-40,122
-86% -$4.83M
IOVA icon
274
Iovance Biotherapeutics
IOVA
$2.76B
$846K 0.03%
104,059
-137,915
-57% -$722K
LYV icon
275
PUT
Live Nation Entertainment
LYV
$42.7B
$845K 0.03%
229,500
+192,000
+512% +$16.5M
9 10
11
12 13

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q4 2023 Portfolio in Review

As of Q4 2023, UBS O'Connor held 672 positions worth $3.18B, down 43% from $5.62B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

UBS O'Connor withdrew a net $2.64B in Q4 2023, closing 169 positions and reducing 251 holdings. Its most notable exit was Activision Blizzard, an estimated $1.06B position sold in full.

By sector, the portfolio is most concentrated in Energy at 30% of assets, up from 3.6% a quarter earlier, followed by Technology and Healthcare.

Against the trend, UBS O'Connor opened a new position in Pioneer Natural Resource Co. worth $579M.

  • UBS O'Connor's largest Q4 2023 buy was Pioneer Natural Resource Co.: 2,576,808 shares worth $579M.
  • UBS O'Connor added most to Splunk Inc in Q4 2023, an estimated $446M increase.
  • UBS O'Connor's biggest Q4 2023 reduction was Capri Holdings, cutting an estimated $36.6M.
  • UBS O'Connor fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
  • UBS O'Connor's ten largest holdings make up 61% of its $3.18B portfolio in Q4 2023.
  • UBS O'Connor opened 112 new positions and closed 169 in Q4 2023.
  • UBS O'Connor's portfolio value fell 43% quarter-over-quarter to $3.18B.

Based on UBS O'Connor's 13F filing for Q4 2023, filed 14 Feb 2024.